GoodRx Holdings, Inc.

Ladies and gentlemen, thank you for standing by, and welcome to the GoodRx fourth quarter and full year 2020 earnings call. As a reminder, today's conference is being recorded. I would now like to introduce your host for today's call, Whitney Notaro, Vice President of Investor Relations. Ms. Notaro, you may begin.

Thank you, Operator. Good afternoon, everyone, and welcome to GoodRx's earnings conference call for the fourth quarter and full year 2020. Joining me today are Doug Hirsch and Trevor Bezdek, our co-founders and co-chief executive officers, and Karsten Vorman, our chief financial officer. Before we begin, I'd like to remind everyone that this call will contain forward-looking statements. All statements made on this call that do not relate to matters of historical fact should be considered forward-looking statements, including statements regarding management's plans, strategies, goals and objectives, our market opportunity, our anticipated financial performance, and the expected impact of COVID-19 on our business. These statements are neither promises nor guarantees, but involve known and unknown risks, uncertainties, and other important factors. These factors may cause our actual results, performance, or achievements to be materially different from any future results, performance, or achievements expressed or implied by the forward-looking statements. Factors discussed in the risk factors section of our annual report on Form 10-K for the year end of December 31st and our other filings with the Securities and Exchange Commission could cause actual results to differ materially from those indicated by the forward-looking statements made on this call. Any such forward-looking statements represent management's estimates as of the date of this call, and we disclaim any obligation to update these statements, even if subsequent events cause our views to change. In addition, we may also reference certain non-GAAP metrics, which are reconciled to the nearest GAAP metric in the company's shareholder letter, which can be found on the overview page of our investor relations website at investors.gooderx.com. I'd also like to remind everyone that a replay of this call will become available there shortly as well. With that, I'll turn the call over to Doug.

Thank you, Whitney, and thanks to all of you for joining us this afternoon. GoodRx's mission to help Americans has never been more important. Over the past year, the COVID-19 pandemic hobbled and overwhelmed our nation's health care system. More than 65% of Americans were financially impacted by the pandemic, forcing more than one in three patients to skip treatment or medications. Over 150 million people sacrificed basic needs to find healthcare or sacrificed their healthcare to meet basic needs. Either way, these kinds of sacrifices have serious, long-lasting consequences for both individuals and our nation. GoodRx has always been laser-focused in providing Americans with access to the care they need at a price they can afford. As the crisis unfolded, we rallied to help. During the pandemic, GoodRx launched a host of new products and initiatives that delivered relief to Americans in need. We doubled down on new, affordable telemedicine services, delivered prescriptions directly to homes, and created more savings opportunities for prescriptions, medical care, labs, and other healthcare services. Doing well by doing good has always been our mantra. Our efforts to help Americans significantly grew our business. We delivered strong performance in 2020 with fast growth at attractive margins and reached new milestones, including over $25 billion of cumulative consumer savings in our prescriptions transactions offering alone, a record number of monthly active consumers, and a 2X increase of subscribers on our platform. In addition to these exciting business milestones, we donated approximately 1.1 million shares valued at over $40 million to GoodRx Helps in the fourth quarter, following through on the commitment we made at the time of our IPO. GoodRx Helps is our charitable initiative to help provide care to people who simply have nowhere else to turn. We've also been focused on diversity, equity, and inclusion within GoodRx as we recognize the importance of reflecting the diversity of our consumers within our own organization. I'm proud to report that in just six months, we have tripled the number of women in leadership positions and prioritized diversity in our recruiting. Today, close to half of our team identifies as people of color. We could not be more proud of the effort and dedication of our team as we continue to build the leading consumer-focused digital healthcare platform. We reach more consumers than ever with an improved and simplified user experience, but we have just scratched the surface of the massive opportunity ahead. We believe that there will be lasting changes to the way Americans find and receive healthcare after the pandemic. Millions of people have embraced telemedicine and home delivery. Millions more are turning to the Internet to learn about their care and the choices available to them. Across the healthcare ecosystem, long-hidden information is flowing more freely, and patients are being empowered to own their healthcare journey. GooderX intends to play a leadership role in post-pandemic healthcare, helping Americans reengage with physicians in care to seek help for chronic and new health challenges. There will likely be a substantial backlog of undiagnosed conditions and neglected preventative care. and we will be there to meet our consumers wherever they need help. We see 2021 as a massive opportunity to bring more value to our consumers at each stage of their healthcare journey. We remain intently focused on continuing to strengthen our brand and broaden our reach, taking our content and insights to the next level, and investing in our platform to launch new products and services. Much has changed over the past year, but one constant remains, our mission to help Americans get the healthcare they need at a price they can afford, and it has never been more relevant. With that, I'll turn it over to Trevor to address key highlights from the quarter and trends in our business.